Related references
Note: Only part of the references are listed.Efficacy of Low Molecular Weight Heparin in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Ventilatory Support
Yongbing Qian et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2014)
Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis
L. N. Roberts et al.
HAEMATOLOGICA (2014)
The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials
D. Sanford et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
The efficacy and safety of low-molecular-weight heparin use for cancer treatment: A meta-analysis
D. H. Che et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Thrombosis in women: what are the knowledge gaps in 2013?
S. Middeldorp
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature
E. Romualdi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Efficacy and safety of adjunctive anticoagulation in patients with lung cancer without indication for anticoagulants: a systematic review and meta-analysis
Jing Zhang et al.
THORAX (2013)
Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: Results from the ABEL study
R. Lecumberri et al.
THROMBOSIS RESEARCH (2013)
Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
David A. Garcia et al.
CHEST (2012)
Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
Clive Kearon et al.
CHEST (2012)
Evidence-Based Management of Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Anne Holbrook et al.
CHEST (2012)
Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity
Debra A. Cockayne et al.
PLOS ONE (2012)
Treatment of established thrombotic events in patients with cancer
Agnes Y. Y. Lee
THROMBOSIS RESEARCH (2012)
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
Freesia Horsted et al.
PLOS MEDICINE (2012)
Long-term Low-Molecular-Weight Heparin and the Post-Thrombotic Syndrome: A Systematic Review
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer
Frederiek F. van Doormaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Home Therapy of Venous Thrombosis with Long-term LMWH versus Usual Care: Patient Satisfaction and Post-thrombotic Syndrome
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy
Matteo Ceccarelli et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
The effect of IVX-0142, a heparin-derived hypersulfated disaccharide, on the allergic airway responses in asthma
M. Duong et al.
ALLERGY (2008)
Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism:: Comparative study of enoxaparin versus coumarin
Jose A. Gonzalez-Fajardo et al.
JOURNAL OF VASCULAR SURGERY (2008)
The anti-inflammatory effects of heparin and related compounds
Edward Young
THROMBOSIS RESEARCH (2008)
Size-fractionated heparins have differential effects on human neutrophil function in vitro
R. Lever et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis
Roberto R. Giraldez et al.
EUROPEAN HEART JOURNAL (2007)
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials
A. Lazo-Langner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction
EM Antman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The post-thrombotic syndrome: The forgotten morbidity of deep venous thrombosis
SR Kahn
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination
Rachel A. Brown et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2006)
Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system
Z Johnson et al.
JOURNAL OF IMMUNOLOGY (2004)
Acute ischemic heart disease - Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
FX Kleber et al.
AMERICAN HEART JOURNAL (2003)
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery - A meta-analysis of 4 randomized double-blind studies
AGG Turpie et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis
C Vancheri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Share Paper
